Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
Acasti to Present at the Life Sciences Investor Forum
Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
Acasti Pharma to Attend BIO International Convention 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.